Sign in with Google
bullish
SanBio Co Ltd (4592 JP): Losses Narrow; AKUUGO Upbeat on Successful Commercial Runs; FY26 Key
274 Views19 Mar 2025 00:30
SanBio reported 23% decline in operating expenses in FY25. The company is preparing for the launch of Akuugo in Q2FY26 and has enough cash runway through FY26, with additional funds raised in March.
What is covered in the Full Insight:
- Introduction
- Financial Performance
- Akuugo’s Commercial Progress
- Future Outlook and Initiatives
- Conclusion
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »- SanBio Co Ltd (4592 JP): Losses Narrow; AKUUGO Upbeat on Successful Commercial Runs; FY26 Key
- SanBio Co Ltd (4592 JP): Full-year FY01/25 flash update
- SanBio Co Ltd (4592 JP): Q3 FY01/25 flash update
- SanBio Co Ltd (4592 JP): Conditional Approval for First Drug; Still a Long Way to Go
- SanBio Co Ltd (4592 JP): 1H FY01/25 flash update
Trending Collections
More »Trending Insights
More »- Seven & I Holdings (3382 JP): Uncomfortable Truths
- Tsuruha (3391) - Welcia (3141) - Tsuruha Earnings In a Week - Still Good To Be Long The Ratio
- Fuji Soft (9749 JP) - KKR Does Deal With the Family To Squeeze Out Minorities - You Can Join Too
- 7&I (3382) - Clarifications of Clarifications But Progress Is Apparent
- Xiaomi (1810 HK)'s US$5bn Placement: Unfavourable Index Dynamics but Strong Momentum
Top Unpaywalled Insights
More »- The Fed's Next Move: How Interest Rates Will Make or Break Your Portfolio
- Overview#20 - Welcome to Bizzaro World!
- Volatility, Tariffs, and a Potential Recession: Breaking Down Macro Chaos | The New Barbarians #011
- Bear Stearns, Tariffs, and the Credit Crisis: Lessons from 2008 | The New Barbarians #012
- Trump Has Already Lost His Trade War
Discussions
(Paid Plans Only)
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- SanBio Co Ltd (4592 JP): Losses Narrow; AKUUGO Upbeat on Successful Commercial Runs; FY26 Key19 Mar 2025
- SanBio Co Ltd (4592 JP): Conditional Approval for First Drug; Still a Long Way to Go20 Sep 2024
- SanBio (4592 JP): Better-Than-Expected Operating Loss in FY23; Product Approval Expected in FY2417 Mar 2023
x